Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Stomach Neoplasms 1Radiodermatitis 1Esophageal Neoplasms 1Dermatitis 1Breast Neoplasms 1

Interventions

Low-Level Light Therapy 6Standard of Care 5Petrolatum 3Norepinephrine 3triethanolamine 2sapropterin 2Sodium Chloride 2Radiotherapy 2Curcumin 2Biafine 2eucerin 1epigallocatechin gallate 1dimethicone 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1calcipotriene 1Zinc Oxide 1Triamcinolone Acetonide 1Thioctic Acid 1Sodium Hypochlorite 1Silver Sulfadiazine 1Radiotherapy, Conformal 1Practice Guidelines as Topic 1Melatonin 1Laser Therapy 1Hydrogel, Polyethylene Glycol Dimethacrylate 1Hydrocortisone 1Gels 1Dimethyl Sulfoxide 1Centella asiatica extract 1Catechin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Radiodermatitis × dimethicone × Clear all
NCT02534129 2017-10-06

Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis

ProTechSure Scientific, Inc.

Phase 1/2 Terminated
13 enrolled 3 charts
Breast

Breast Neoplasms, Dermatitis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡